Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication - sprookjes - yvandenbroek - TriplyDB

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

http://www.wikidata.org/entity/Q24651415

about

Regulation of hepatic innate immunity by hepatitis C virus STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.Interferon-λ in HCV Infection and Therapy.New antiviral therapies for chronic hepatitis C IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.Potential treatment options and future research to increase hepatitis C virus treatment response rate Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks.Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.Interferon lambdas: the next cytokine storm Activation and evasion of antiviral innate immunity by hepatitis C virus.Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.Recent advances in the anti-HCV mechanisms of interferon.IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.The genetic theory of infectious diseases: a brief history and selected illustrations.Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression The IFN-λ Genetic Polymorphism Association With the Viral Clearance Induced by Hepatitis C Virus Treatment in Pakistani Patients.Impact of aging on dendritic cell functions in humans.Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.Host genetic basis for hepatitis C virus clearance: a role for blood collection centers IL28B and the control of hepatitis C virus infection.The IL-28 genotype: how it will affect the care of patients with hepatitis C virus infection.Interferon combination therapy for HIV/hepatitis C virus coinfection.Host genomics and HCV treatment response.Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.IL-28 and IL-29 as protective markers in subject with dengue fever.Effect of Interleukin-29 on Interferon-α Secretion by Peripheral Blood Mononuclear Cells.IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities.Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins.

P2860

Q26824743-7F1B5004-02F9-48EF-B68C-8EC2DDED6181 Q27000742-EF39484C-13A0-4743-B8B1-9B4F92F75ED3 Q27335125-E2970780-7292-4556-A65A-7DA38AD466E2 Q33729001-2AB4D5A2-E109-4196-BD2B-080330D4D0A1 Q33775597-1C643D13-EBC4-4C63-8383-3F16CA1A2C29 Q34047500-EEA81E64-FA95-46D7-BFF6-3B5029502B48 Q34130399-C65A9BEA-3D7B-46C4-A60B-0FBEA7EBAAF7 Q34147632-C6341C76-BC76-4DFE-B153-2BA6656861C7 Q34576190-D2F0E366-5095-4AE0-95B0-D971C5E27C8B Q34721253-A3FC6F12-1ACA-4C5C-9146-753BD29ECCBB Q34734013-929352BA-756E-4415-BF65-7B45AA44D715 Q34750577-BFF10B3F-3717-4D67-B96B-CACCFC1C939C Q35042843-8701105D-ACC7-4A80-8C7E-5A10DC43123E Q35097482-77292519-877D-449C-9557-2AEB690D9B7C Q35154826-6FC30FD9-522A-4D91-869B-DA9460582168 Q35606341-8BFB3464-2429-4692-9C2E-1C228701EF45 Q36030292-A34A06C5-1229-4F71-9722-FCEE6FB74593 Q36237584-0675E54A-91F5-4547-9912-DC64715FE99C Q36248186-88D6616B-8BFC-4E0F-BD6D-59D5BC4FFBE3 Q36829191-C91920C5-F107-4483-8B01-DBD8243AB578 Q36890411-A9B7E955-8F10-4606-BA70-05075AF579EF Q37166962-1F7E75AA-BB2C-4F70-8FB5-20E4EC1160E0 Q37604941-D6E62984-0EDE-4FE4-A93D-AB06A3514CFF Q37604952-E3E2E0D9-2F61-49B6-9D51-1F636C2E5B27 Q37610149-1E26C99E-2260-451A-AE74-C3D5122E4F28 Q37699253-7F3C1E62-6683-42FC-B958-835F8D2DDC68 Q37771485-A6AE1896-5DF3-47D8-AAE8-8565D28C69F2 Q37774371-7C369A1E-D38C-4442-8DF7-F04473CAD040 Q37781667-A54B1BEE-CCD2-4CFC-979F-FFF4F36D5ED8 Q37800518-53026CD7-AF04-4A41-97DB-61F23E1C6A5C Q37809806-E0192EAC-DE6C-4EA1-8659-7DFE73D735B7 Q37931258-929BD405-B74F-4BB8-BEAF-B87886ABB205 Q37932036-E0382590-F256-45A7-95B4-E9D746B9F72C Q38136078-2DC9B551-030D-4EF7-91B6-D4FE03E5F864 Q38941741-DCFE55DC-F9FD-4E73-BD81-FF0E0E1AFD0E Q39038507-8E4C16D1-1EE2-405A-97E5-CB427E6225F2 Q39181189-063A302E-4D25-4FD1-AF74-3805FEA095CB Q39725612-676E425A-094F-4671-BCC0-B863CC93D4D1 Q39747657-0E6F28C7-9FDA-4223-8C39-3EF4749D741F Q39758342-61251873-81A5-45C1-921C-2879F0583E6A

P2860

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

http://www.wikidata.org/entity/Q24651415

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Interleukin-29 functions coope ...... hepatitis C virus replication

@ast

Interleukin-29 functions coope ...... hepatitis C virus replication

@en

Interleukin-29 functions coope ...... hepatitis C virus replication

@nl

type

label

Interleukin-29 functions coope ...... hepatitis C virus replication

@ast

Interleukin-29 functions coope ...... hepatitis C virus replication

@en

Interleukin-29 functions coope ...... hepatitis C virus replication

@nl

altLabel

Interleukin-29 Functions Coope ...... Hepatitis C Virus Replication

@en

prefLabel

Interleukin-29 functions coope ...... hepatitis C virus replication

@ast

Interleukin-29 functions coope ...... hepatitis C virus replication

@en

Interleukin-29 functions coope ...... hepatitis C virus replication

@nl

P1433

Q24651415-662567A0-2C55-421D-97E5-1806F048C85A

P1476

Q24651415-4A2A041B-5EB9-48AC-9423-C2CD8C2E3B5F

P2093

Q24651415-10B1C83A-6078-4BC2-A62E-280629197BE7

Q24651415-411233C5-D5B4-4322-9E32-F0E02FF25692

Q24651415-AC14E818-392E-4688-9927-0E04554506F4

Q24651415-B457162C-B1A7-44A3-8C08-A03F542EDECA

Q24651415-CB1814AA-E04C-4680-8D02-B5EFB108AD2C

Q24651415-DF03EA85-79FB-495F-9D69-B9FD0FDC2A72

P2860

Q24651415-00C7F02E-278D-464D-A273-2A47140F3CAE

Q24651415-0322FF64-FECF-4DE5-84E9-D5F0704610C9

Q24651415-195E8753-7E21-4B71-9019-464B320EFF04

Q24651415-1C9D717A-5DA0-4CED-BAF8-D80A19959BE2

Q24651415-1FA5CD1D-5C14-45D3-8261-7EBF7A730152

Q24651415-25E3FE18-9CBC-41F6-86B2-287AC6B13851

Q24651415-28FD251D-F0BE-4381-B316-03B38D9618D1

Q24651415-2AB7BA01-DC88-452E-87EA-7C41483D2A46

Q24651415-2AB9DB1A-68D0-4EA4-B165-BD89A0773CE6

Q24651415-32BF4ECA-785C-4BD8-8A0C-623E463B2AF7

P304

Q24651415-8B924A22-C04C-403E-A661-BFA857AD9AB6

P31

Q24651415-045374AF-9680-4976-A32E-261B2E035931

P356

Q24651415-0A6B75F6-C2B4-4920-AD4E-B025F4989C65

P407

Q24651415-FC597810-A7BD-4D29-A5AB-DC10A0B3F6D7

P433

Q24651415-1C59EE1F-4433-4629-947B-26834005FED7

P478

Q24651415-478D13D5-A3FD-40A1-927D-54934DEFCA83

P577

Q24651415-47577B9B-5FF9-4CCD-9CEE-40C8F560ECF5

P698

Q24651415-2BB770FB-631A-4956-B8E0-6025CE94FB8A

P921

Q24651415-ECDE04D4-CD0C-4203-A6B7-D7CF48BFC77B

Q24651415-e3bfe2ec-91e0-482a-a321-0ec910b259c4

P932

Q24651415-1B8E1ED6-3E16-40F8-A13D-80E3887833FD

P356

P1433

Journal of Biological Chemistry

P1476

Interleukin-29 functions coope ...... hepatitis C virus replication

@en

P2093

Michael D Robek

http://www.w3.org/2001/XMLSchema#string

Nicole E Pagliaccetti

http://www.w3.org/2001/XMLSchema#string

Prasanthi Bandi

http://www.w3.org/2001/XMLSchema#string

Roger Eduardo

http://www.w3.org/2001/XMLSchema#string

Steven H Kleinstein

http://www.w3.org/2001/XMLSchema#string

Xinmeng Jasmine Mu

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Activities of IRF-1

Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling

Biological activity of interleukins-28 and -29: comparison with type I interferons

IL-28, IL-29 and their class II cytokine receptor IL-28R

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

A single DNA response element can confer inducibility by both alpha- and gamma-interferons

Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus

The human genome browser at UCSC

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma

P304

30079-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M804296200

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18757365

http://www.w3.org/2001/XMLSchema#string

P921

P932

2662072

http://www.w3.org/2001/XMLSchema#string